Erkki Seppälä
Impact in
- Endocrine and Autonomic Systems top 10%
- Neuroscience of respiration and sleep
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
Papers in
- Pharmacology 26
- Inflammatory mediators and NSAID effects 21
-
- Antiplatelet Therapy and Cardiovascular Diseases 7
- Co-authors
- Heikki Vapaatalo (40 shared papers)Jóel Hasan (2 shared papers)Seppo Saarelainen (2 shared papers)T. Metsä‐Ketelä (5 shared papers)H Isomäki (6 shared papers)Jussi K. Huttunen (4 shared papers)Seppo Kaukinen (11 shared papers)A. Aro (2 shared papers)
In The Last Decade
Erkki Seppälä
58 papers receiving 801 citations
Peers
Comparison fields: 5 of 104
- Endocrine and Autonomic Systems 102
- Pharmacology 250
- Biochemistry 92
- Physiology 273
- Nutrition and Dietetics 121
Countries citing papers authored by Erkki Seppälä
This map shows the geographic impact of Erkki Seppälä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkki Seppälä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkki Seppälä more than expected).
Fields of papers citing papers by Erkki Seppälä
This network shows the impact of papers produced by Erkki Seppälä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkki Seppälä. The network helps show where Erkki Seppälä may publish in the future.
Co-authors
The 25 scholars most cited alongside Erkki Seppälä, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 77 | |
| 2 | 1984 | 66 | |
| 3 | 1996 | 53 | |
| 4 | 1984 | 46 | |
| 5 | 1989 | 44 | |
| 6 | Evening primose oil and fish oil are ineffective as supplementary treatment of bronchial asthma. | 1989 | 41 |
| 7 | 1985 | 41 | |
| 8 | 1985 | 37 | |
| 9 | 1988 | 33 | |
| 10 | 1984 | 31 | |
| 11 | 1985 | 24 | |
| 12 | 1986 | 24 | |
| 13 | Adrenaline stimulates thromboxane and inhibits leukotriene synthesis in man. | 1992 | 24 |
| 14 | 1990 | 21 | |
| 15 | 1997 | 21 | |
| 16 | 1985 | 21 | |
| 17 | 1986 | 15 | |
| 18 | 2000 | 12 | |
| 19 | 1988 | 12 | |
| 20 | 1985 | 12 |
About Erkki Seppälä
Erkki Seppälä is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine, Biochemistry, Physiology and Molecular Biology, having authored 60 papers that have together received 872 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (21 papers), Eicosanoids and Hypertension Pharmacology (10 papers), Fatty Acid Research and Health (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Nitric Oxide and Endothelin Effects (5 papers), Analytical Methods in Pharmaceuticals (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Hormonal Regulation and Hypertension (4 papers). The work is most often cited by research in Endocrine and Autonomic Systems (102 citations), Pharmacology (250 citations), Biochemistry (92 citations), Physiology (273 citations) and Nutrition and Dietetics (121 citations). Erkki Seppälä has collaborated with scholars based in Finland, Hungary and Sweden. Frequent co-authors include Heikki Vapaatalo, Jóel Hasan, Seppo Saarelainen, T. Metsä‐Ketelä, H Isomäki, Jussi K. Huttunen, Seppo Kaukinen, A. Aro, K. Laustiola and Ossi Laitinen. Their work appears in journals such as Clinical Rheumatology, Scandinavian Journal of Rheumatology, Journal of Cardiovascular Pharmacology, Prostaglandins Leukotrienes and Essential Fatty Acids and Inflammation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.